Loading…

Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study

Background Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe. Results Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from...

Full description

Saved in:
Bibliographic Details
Published in:Cancer nanotechnology 2023-12, Vol.14 (1), p.6-17, Article 6
Main Authors: Swidan, Mohamed M., Essa, Basma M., Sakr, Tamer M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33
cites cdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33
container_end_page 17
container_issue 1
container_start_page 6
container_title Cancer nanotechnology
container_volume 14
creator Swidan, Mohamed M.
Essa, Basma M.
Sakr, Tamer M.
description Background Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe. Results Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior. Conclusions In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.
doi_str_mv 10.1186/s12645-023-00157-y
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_968515f73be346a0ad74aca565bcc1f3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_968515f73be346a0ad74aca565bcc1f3</doaj_id><sourcerecordid>2771822026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhSMEElXpC7CyxDpc_yROzA5VQCtVogtYW3Ptceqr1L7YzoX0MXhi3AaVHd6MNT7nm5FP07xl9D1jo9xlxmXXt5SLllLWD-36ojmrD2MrlZQvn-_9-Lq5yPlA6xFKKarOmt-3yefiA-5cnKFg65Zgio8BZv-AlkwJjncYkMRf3iKBTMrPSHwoyYfsDczzShJYH320PlSAJQFCbMsdplor2uQPJOPsdnaBuTrJyZ8iKZAmrHMnYuL9ERIUf0KSy2LXN80rB3PGi7_1vPn--dO3y6v25uuX68uPN60RvSqtACaNQqsGoToLIzjqOuHcSJVg46CoFGYvELjplVSd7KhhY8eBchiQgxDnzfXGtREO-pj8PaRVR_D6qRHTpCHV_WfUSo49690g9ig6CRTs0IGBXvZ7Y5h7ZL3bWMcUfyyYiz7EJdVPzJoPAxs5p1xWFd9UJsWcE7rnqYzqxyj1FqWuUeqnKPVaTWIz5SoOE6Z_6P-4_gAjGKWL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2771822026</pqid></control><display><type>article</type><title>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access</source><creator>Swidan, Mohamed M. ; Essa, Basma M. ; Sakr, Tamer M.</creator><creatorcontrib>Swidan, Mohamed M. ; Essa, Basma M. ; Sakr, Tamer M.</creatorcontrib><description>Background Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe. Results Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior. Conclusions In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.</description><identifier>ISSN: 1868-6958</identifier><identifier>EISSN: 1868-6966</identifier><identifier>DOI: 10.1186/s12645-023-00157-y</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Biochemistry ; Biocompatibility ; Biomedical Engineering and Bioengineering ; Cancer Research ; Cerium gadolinium oxides ; Chemistry and Materials Science ; Comparative studies ; Folic acid ; Graphene ; Graphene oxide nanosheets ; In vivo methods and tests ; Intrinsic radioiodination ; Materials Science ; Nanoplatform ; Nanostructure ; Nanotechnology ; Radioactive tracers ; Theranostic ; Toxicity ; Tumor ; Tumors</subject><ispartof>Cancer nanotechnology, 2023-12, Vol.14 (1), p.6-17, Article 6</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</citedby><cites>FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2771822026/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2771822026?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25732,27903,27904,36991,44569,74872</link.rule.ids></links><search><creatorcontrib>Swidan, Mohamed M.</creatorcontrib><creatorcontrib>Essa, Basma M.</creatorcontrib><creatorcontrib>Sakr, Tamer M.</creatorcontrib><title>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</title><title>Cancer nanotechnology</title><addtitle>Cancer Nano</addtitle><description>Background Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe. Results Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior. Conclusions In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.</description><subject>Biochemistry</subject><subject>Biocompatibility</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Cancer Research</subject><subject>Cerium gadolinium oxides</subject><subject>Chemistry and Materials Science</subject><subject>Comparative studies</subject><subject>Folic acid</subject><subject>Graphene</subject><subject>Graphene oxide nanosheets</subject><subject>In vivo methods and tests</subject><subject>Intrinsic radioiodination</subject><subject>Materials Science</subject><subject>Nanoplatform</subject><subject>Nanostructure</subject><subject>Nanotechnology</subject><subject>Radioactive tracers</subject><subject>Theranostic</subject><subject>Toxicity</subject><subject>Tumor</subject><subject>Tumors</subject><issn>1868-6958</issn><issn>1868-6966</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kc1u1TAQhSMEElXpC7CyxDpc_yROzA5VQCtVogtYW3Ptceqr1L7YzoX0MXhi3AaVHd6MNT7nm5FP07xl9D1jo9xlxmXXt5SLllLWD-36ojmrD2MrlZQvn-_9-Lq5yPlA6xFKKarOmt-3yefiA-5cnKFg65Zgio8BZv-AlkwJjncYkMRf3iKBTMrPSHwoyYfsDczzShJYH320PlSAJQFCbMsdplor2uQPJOPsdnaBuTrJyZ8iKZAmrHMnYuL9ERIUf0KSy2LXN80rB3PGi7_1vPn--dO3y6v25uuX68uPN60RvSqtACaNQqsGoToLIzjqOuHcSJVg46CoFGYvELjplVSd7KhhY8eBchiQgxDnzfXGtREO-pj8PaRVR_D6qRHTpCHV_WfUSo49690g9ig6CRTs0IGBXvZ7Y5h7ZL3bWMcUfyyYiz7EJdVPzJoPAxs5p1xWFd9UJsWcE7rnqYzqxyj1FqWuUeqnKPVaTWIz5SoOE6Z_6P-4_gAjGKWL</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Swidan, Mohamed M.</creator><creator>Essa, Basma M.</creator><creator>Sakr, Tamer M.</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><general>BMC</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0S</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>DOA</scope></search><sort><creationdate>20231201</creationdate><title>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</title><author>Swidan, Mohamed M. ; Essa, Basma M. ; Sakr, Tamer M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biochemistry</topic><topic>Biocompatibility</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Cancer Research</topic><topic>Cerium gadolinium oxides</topic><topic>Chemistry and Materials Science</topic><topic>Comparative studies</topic><topic>Folic acid</topic><topic>Graphene</topic><topic>Graphene oxide nanosheets</topic><topic>In vivo methods and tests</topic><topic>Intrinsic radioiodination</topic><topic>Materials Science</topic><topic>Nanoplatform</topic><topic>Nanostructure</topic><topic>Nanotechnology</topic><topic>Radioactive tracers</topic><topic>Theranostic</topic><topic>Toxicity</topic><topic>Tumor</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swidan, Mohamed M.</creatorcontrib><creatorcontrib>Essa, Basma M.</creatorcontrib><creatorcontrib>Sakr, Tamer M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer nanotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swidan, Mohamed M.</au><au>Essa, Basma M.</au><au>Sakr, Tamer M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</atitle><jtitle>Cancer nanotechnology</jtitle><stitle>Cancer Nano</stitle><date>2023-12-01</date><risdate>2023</risdate><volume>14</volume><issue>1</issue><spage>6</spage><epage>17</epage><pages>6-17</pages><artnum>6</artnum><issn>1868-6958</issn><eissn>1868-6966</eissn><abstract>Background Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe. Results Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior. Conclusions In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><doi>10.1186/s12645-023-00157-y</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1868-6958
ispartof Cancer nanotechnology, 2023-12, Vol.14 (1), p.6-17, Article 6
issn 1868-6958
1868-6966
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_968515f73be346a0ad74aca565bcc1f3
source Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access
subjects Biochemistry
Biocompatibility
Biomedical Engineering and Bioengineering
Cancer Research
Cerium gadolinium oxides
Chemistry and Materials Science
Comparative studies
Folic acid
Graphene
Graphene oxide nanosheets
In vivo methods and tests
Intrinsic radioiodination
Materials Science
Nanoplatform
Nanostructure
Nanotechnology
Radioactive tracers
Theranostic
Toxicity
Tumor
Tumors
title Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A04%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pristine/folate-functionalized%20graphene%20oxide%20as%20two%20intrinsically%20radioiodinated%20nano-theranostics:%20self/dual%20in%20vivo%20targeting%20comparative%20study&rft.jtitle=Cancer%20nanotechnology&rft.au=Swidan,%20Mohamed%20M.&rft.date=2023-12-01&rft.volume=14&rft.issue=1&rft.spage=6&rft.epage=17&rft.pages=6-17&rft.artnum=6&rft.issn=1868-6958&rft.eissn=1868-6966&rft_id=info:doi/10.1186/s12645-023-00157-y&rft_dat=%3Cproquest_doaj_%3E2771822026%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2771822026&rft_id=info:pmid/&rfr_iscdi=true